• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles Benzothiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzothiazoles

Introduction to 4,6-Dibromo-2-chlorobenzothiazole (CAS No: 1188141-65-2)

4,6-Dibromo-2-chlorobenzothiazole (CAS No: 1188141-65-2) is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its versatile structural properties. This compound belongs to the benzothiazole class, which is well-known for its broad spectrum of biological activities. The presence of both bromo and chloro substituents on the benzothiazole core enhances its reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The chemical structure of 4,6-Dibromo-2-chlorobenzothiazole consists of a benzene ring fused with a thiazole ring, with bromine atoms at the 4- and 6-positions and a chlorine atom at the 2-position. This specific arrangement imparts unique electronic and steric properties to the molecule, which can be exploited in drug design and development. The compound's ability to act as a scaffold for further functionalization has made it a subject of intense study in medicinal chemistry.

In recent years, 4,6-Dibromo-2-chlorobenzothiazole has been explored as a key intermediate in the synthesis of novel therapeutic agents. Its derivatives have shown promising activities against various diseases, including cancer, infectious diseases, and inflammatory disorders. The benzothiazole core is particularly noteworthy for its role in antimicrobial and antiviral applications. For instance, studies have demonstrated that modifications of the benzothiazole ring can lead to compounds with enhanced efficacy against drug-resistant pathogens.

One of the most compelling aspects of 4,6-Dibromo-2-chlorobenzothiazole is its potential in oncology research. Researchers have identified that certain derivatives of this compound exhibit inhibitory effects on kinases and other enzymes involved in tumor growth and progression. The bromo and chloro substituents serve as handles for further chemical modification, allowing chemists to fine-tune the pharmacokinetic properties of these derivatives. This flexibility has led to the development of several lead compounds that are currently undergoing preclinical evaluation.

The agrochemical industry has also recognized the significance of 4,6-Dibromo-2-chlorobenzothiazole as a precursor for novel pesticides. Its structural features make it an effective candidate for synthesizing compounds that target pest-specific enzymes and receptors. Such derivatives have shown potential in controlling agricultural pests while maintaining environmental safety. The ability to modify the benzothiazole core allows for the creation of compounds with improved selectivity and reduced toxicity to non-target organisms.

From a synthetic chemistry perspective, 4,6-Dibromo-2-chlorobenzothiazole offers a rich platform for exploring new reaction pathways and methodologies. The presence of multiple reactive sites enables chemists to employ various coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, to introduce additional functional groups. These reactions are crucial for generating complex molecular architectures that mimic natural products or designed biologics.

Recent advances in computational chemistry have further enhanced the utility of 4,6-Dibromo-2-chlorobenzothiazole in drug discovery. Molecular modeling studies have helped predict the binding modes of its derivatives to biological targets, providing insights into their mechanism of action. This computational approach has accelerated the design process by allowing researchers to prioritize promising candidates based on their predicted affinity and selectivity.

The industrial production of 4,6-Dibromo-2-chlorobenzothiazole has also seen significant improvements in recent years. Process optimization has led to more efficient synthetic routes, reducing costs and minimizing waste generation. These advancements are crucial for ensuring the scalability of pharmaceutical applications where cost-effectiveness and sustainability are paramount.

In conclusion,4,6-Dibromo-2-chlorobenzothiazole (CAS No: 1188141-65-2) is a multifaceted compound with broad applications in pharmaceuticals and agrochemicals. Its unique structural features make it an excellent scaffold for developing novel therapeutic agents with diverse biological activities. As research continues to uncover new derivatives and applications,4,6-Dibromo-2-chlorobenzothiazole is poised to remain at the forefront of medicinal chemistry innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)